'I know it seems insane.' Cancer survivor riding motorcycle 3,800 miles to Alaska
Not many people appreciate potholes, but Dan Winkelman is not most people.
Winkleman, of Stevens Point, initially attributed a pain in his back to a pothole he had just hit on a 2018 motorcycle ride in Myanmar, where he was working as a missionary. A doctor there chalked it up to a sprained muscle. But the pain persisted, so he pushed for a CT scan at a better hospital in Bangkok. The scan showed a tumor.
Stage 3 pancreatic cancer. The disease has a 12% five-year survival rate among patients of all stages.
Nearly seven years, two chemotherapy treatments and one surgery later, Winkelman is cancer free. Medical College of Wisconsin cancer surgeon Douglas Evans puts the chance of Winkelman's cancer returning at just 2%.
"That's why I always say potholes are beautiful," Winkelman, 69, said. "If I hadn't hit that pothole and strained my back, they would have never found that tumor."
Winkelman wants to give back to the institution that gave him a second life. He's trying to raise $1.2 million for a Medical College clinical trial in the hope that new pancreatic cancer treatments can be found and more lives can be saved.
To raise the massive sum of money, Winkelman will leave Wisconsin on his motorcycle June 13. He's asking people to pledge money as he rides 3,800 miles, all the way to Anchorage, Alaska.
He's OK if he hits a few potholes along the way.
Winkelman has always had an adventorous spirit. His life is marked by major pivots.
Born in Huntington, Indiana, he spent the summer after his junior year of high school in Alaska, then decided to stay there for his senior year on a whim. He enlisted in the Air Force at age 17, and was part of a search and rescue squadron stationed at NKP Royal Thai Air Force Base toward the end of the Vietnam War.
Winkelman moved to Wisconsin at 32 as one of the first employees of a new railroad company, the Wisconsin Central Railroad, in northern Wisconsin. Sixteen years later, he quit, giving up a lucrative retirement package to become a pastor.
Then at 59, he and his wife, Sandy, moved to Myanmar to serve as missionaries.
"I've had these ideas all my life," Winkelman said. "I like doing things way bigger than me."
Pancreatic cancer often sounds like a death sentence. It's the third-leading cause of cancer death in adults nationally, and the second in Wisconsin.
Evans, who treats patients at the Froedtert and Medical College of Wisconsin Clinical Cancer Center, has dedicated his career to finding treatments for this deadly disease and improving survival rates. Even in his personal life, the pancreas prevails. He enjoys sailing on Lake Michigan and decks his boats with purple ribbons, the color designated for pancreatic cancer awareness.
Evans' interest in the pancreas, a small organ deep in the belly that regulates blood sugar and aids in digestion, came through a fluke. In the late 1970s, his heart was set on his state flagship, the University of Massachusetts Amherst, for medical school. It offered the best deal. A rejection put him at the much pricier Boston University, where his financial aid included overseeing two undergraduate dorms filled with lively students that made it difficult for him to study.
Seeking refuge, Evans took a part-time job at the famed Lahey Clinic across the street. It gave him access to the building's library, and to some of the most well-known pancreas surgeons in the world at that time.
Evans arrived at the Medical College in 2009 and has helped build the institution into one of the premier places in the U.S. for the treatment of pancreatic cancer. The college's LaBahn Pancreatic Cancer Program has led the way in personalized medicine and the application of precision medicine, which is tailoring a patient's treatment based on their genetic makeup and tumor characteristics. The Seena Magowitz Pancreatic Cancer Foundation supports the college, giving more than $1.4 million to support pancreatic cancer research.
Winkelman's first chemotherapy treatment made him violently sick. It was also ineffective; his cancer count continued to rise, not fall. Evans switched him to a different type of treatment, followed by radiation. Winkelman responded well.
Evans was optimistic about his patient's recovery. Winkelman's tumor was localized to the pancreas. It hadn't spread to other organs, though it had encased some important blood vessels, making his tumor inoperable at most medical centers in this country.
In an eight-hour surgery in 2019, Evans removed part of Winkelman's pancreas and took a vein out of his leg to reconstruct an artery the tumor had encased, a procedure developed by Medical College surgeons.
Recovery was rough. Weakened, Winkelman battled a number of infections. Motorcycle rides were out of the question. He eventually sold the bike, doubting he would ever be able to handle his 800-pound motorcycle again.
Winkelman sometimes struggles with survivor's guilt. So few pancreatic cancer patients reach the five-year anniversary of their diagnosis.
"There is a part of me that says, 'OK, why did I get the second chance? Why did I survive?" Winkelman asked.
These lingering questions fueled Winkelman's drive to do something. He wants to raise awareness about the disease, highlight the work being done at Froedtert and the Medical College and offer encouragement to cancer patients through videos he will post daily on his donation website.
He knows the journey won't be easy. His longest motorcycle ride since his diagnosis was to South Dakota's Black Hills. The Alaskan journey will be about four times as long, on a much smaller bike he bought in 2024.
Winkelman has worked with a trainer to build his core muscles, which he will need to fight the wind on the Alaska-Canada Highway. He expects the journey to take 18 days, or about 350 miles per day. His oldest son, Andy, is driving alongside him in an SUV that will pull a camper-trailer.
"It's a crazy deal, isn't it? To think about doing this?" he said. "I know it seems insane."
To his doctor, though, it's not. Evans commended Winkelman's attitude, saying he's a great example of the mind-body relationship at work.
"There was never a doubt he would be here six years later, about to ride his motorcycle to some crazy place," Evans said.
For more information about Winkelman's fundraising campaign, visit give.classy.org/hopeontheroad.
Kelly Meyerhofer has covered higher education in Wisconsin since 2018 but also enjoys stories off the beaten path of college campuses. She would love to hear your story, or someone's you think she should share. Contact her at kmeyerhofer@gannett.com or 414-223-5168. Follow her on X (Twitter) at @KellyMeyerhofer.
This article originally appeared on Milwaukee Journal Sentinel: Cancer survivor riding to Alaska for Medical College of Wisconsin fundraiser
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 hours ago
- Yahoo
US lawmakers pass tougher penalties for fentanyl traffickers
The US Congress on Thursday passed a bill imposing harsher penalties on fentanyl traffickers, with lawmakers from both parties anxious to crack down on an opioid that has driven an epidemic of deadly overdoses. The Senate-passed bill -- which delivers on a key election pledge of President Donald Trump to get tough on drug smuggling -- was rubber-stamped by the House on a 321-104 vote, with Democrats providing all but one of the no votes. The Justice Department says 75,000 Americans die each year because of fentanyl, making it the number one cause of death for people between the ages of 18 and 34 in the United States. The synthetic opioid is more potent than heroin and much cheaper to produce. "More Americans die of drug overdoses each year than the number of Americans who died in the entirety of the Vietnam War," Republican Senate Majority Leader John Thune said ahead of the vote. The HALT Fentanyl Act places copycat variations of fentanyl -- often sold by traffickers -- on the government's list of most dangerous "Schedule 1" drugs alongside the original substance. Lab-created fentanyl alternatives were reclassified to "Schedule 1" on a temporary basis seven years ago but the vote makes the change permanent. Trump has made halting the flow of fentanyl one of his priorities, even announcing it as a justification for import tariffs on Mexico and Canada. But opponents said the new law -- rather than tackling overdoses -- would simply repeat the mistakes of the so-called "War on Drugs." The Leadership Conference on Civil and Human Rights, a coalition of more than 240 US rights organizations, said in a statement the measure would "exacerbate pretrial detention, mass incarceration, and racial disparities in the prison system." "Beginning in the 1980s, draconian drug laws with harsh mandatory minimums and their resulting enforcement under the banner of the 'war on drugs' fueled skyrocketing prison populations," it said. ft/acb
Chicago Tribune
17 hours ago
- Chicago Tribune
Matteson man who survived prostate cancer spreading the word about early detection
Andrin 'AJ' Jones got some scary news when he was diagnosed with prostate cancer, but his experience has pushed him to try to make a difference in other men's lives now that he's a survivor. Jones, a 62-year-old retired Air Force veteran, counts himself lucky that his cancer was caught early enough that it had not spread, so that surgically removing his prostate in 2023 left him healthy. So he wants to spread that good fortune to others by spreading his story about how early testing leads to better outcomes. 'My prognosis was excellent because the biopsy showed the cancer was still contained within the walls of my prostate,' said Jones, who lives in Matteson with his wife, also an Air Force veteran. 'Because of early detection, it had not yet metastasized, the risk level was low to intermediate. I was so thankful for that.' His journey with prostate cancer started in May 2022, when Dr. Lance Wallace, his internist at Specialty Physicians of Illinois, LLC, ordered a full panel of screening labs, including a prostate specific antigen test. That test revealed he had an elevated level of that antigen in his blood. After Wallace saw the test result, he waited a few months to recheck the labs, but they were higher. So he referred Andrin to Dr. James Siegert, a urologist and urological surgeon, also with Specialty Physicians of Illinois, LLC, and practicing with Franciscan Health Olympia Fields, who redid the labs to watch for a trend in elevations. He did the biopsy several months later and found Stage 2 adenocarcinoma. 'Of course I was alarmed at the diagnosis, but at the same time, it was a good reality check to encourage men to not ignore any symptoms,' said Andrin. Andrin said he was given a choice of radiation or surgery and opted for the latter. Siegert said prostate cancer screening was generally recommended for 50- to 60-year-old men at average risk, but for those at increased risk, such as African-American men or those with a family history, the age recommendation drops to 40 to 45. The screening is not usually recommended for men 70 or older. 'Prostate cancer screening is important because it can help detect cancer early, when it's most treatable and potentially curable,' Siegert said. 'Early detection through a PSA blood test may allow patients to avoid more serious complications down the line and preserve their quality of life.' Wallace, Jones' primary care physician, also encouraged early screening. 'Like anything, the earlier you catch it, the less treatment will be involved in treating the cancer, and the chance for success is greater,' Wallace said. Jones said there were a few things that helped him get through the experience, including building a strong relationship with both physicians. 'I'm a person of faith, I trusted God with the situation,' he said. 'I started going for walks in the morning to mentally process things that were going on. 'Along with my wife, family, and church family, that helped me have a good mental perspective,' he said. No matter how difficult the ordeal was he often reminds himself, 'I had cancer — today I don't.' 'Being honest and open with other men about prostate screening' has provided a source of strength for Jones, he said. He still does that on regular walks with his comrades. He also teaches classes on the Bible and is an avid hiker and biker. Siegert said he was struck by Jones' resilience. 'Of the hundreds of men I diagnose and treat for prostate cancer per year, Mr. Jones was unique as throughout his treatment, he maintained a remarkably positive attitude, approaching each step with resilience and hope,' said Siegert. 'Inspired by his experience, he has become a passionate advocate for prostate cancer awareness and early screening, particularly within the African-American and veteran communities, using his voice to encourage others to take charge of their health.'
Yahoo
a day ago
- Yahoo
'I know it seems insane.' Cancer survivor riding motorcycle 3,800 miles to Alaska
Not many people appreciate potholes, but Dan Winkelman is not most people. Winkleman, of Stevens Point, initially attributed a pain in his back to a pothole he had just hit on a 2018 motorcycle ride in Myanmar, where he was working as a missionary. A doctor there chalked it up to a sprained muscle. But the pain persisted, so he pushed for a CT scan at a better hospital in Bangkok. The scan showed a tumor. Stage 3 pancreatic cancer. The disease has a 12% five-year survival rate among patients of all stages. Nearly seven years, two chemotherapy treatments and one surgery later, Winkelman is cancer free. Medical College of Wisconsin cancer surgeon Douglas Evans puts the chance of Winkelman's cancer returning at just 2%. "That's why I always say potholes are beautiful," Winkelman, 69, said. "If I hadn't hit that pothole and strained my back, they would have never found that tumor." Winkelman wants to give back to the institution that gave him a second life. He's trying to raise $1.2 million for a Medical College clinical trial in the hope that new pancreatic cancer treatments can be found and more lives can be saved. To raise the massive sum of money, Winkelman will leave Wisconsin on his motorcycle June 13. He's asking people to pledge money as he rides 3,800 miles, all the way to Anchorage, Alaska. He's OK if he hits a few potholes along the way. Winkelman has always had an adventorous spirit. His life is marked by major pivots. Born in Huntington, Indiana, he spent the summer after his junior year of high school in Alaska, then decided to stay there for his senior year on a whim. He enlisted in the Air Force at age 17, and was part of a search and rescue squadron stationed at NKP Royal Thai Air Force Base toward the end of the Vietnam War. Winkelman moved to Wisconsin at 32 as one of the first employees of a new railroad company, the Wisconsin Central Railroad, in northern Wisconsin. Sixteen years later, he quit, giving up a lucrative retirement package to become a pastor. Then at 59, he and his wife, Sandy, moved to Myanmar to serve as missionaries. "I've had these ideas all my life," Winkelman said. "I like doing things way bigger than me." Pancreatic cancer often sounds like a death sentence. It's the third-leading cause of cancer death in adults nationally, and the second in Wisconsin. Evans, who treats patients at the Froedtert and Medical College of Wisconsin Clinical Cancer Center, has dedicated his career to finding treatments for this deadly disease and improving survival rates. Even in his personal life, the pancreas prevails. He enjoys sailing on Lake Michigan and decks his boats with purple ribbons, the color designated for pancreatic cancer awareness. Evans' interest in the pancreas, a small organ deep in the belly that regulates blood sugar and aids in digestion, came through a fluke. In the late 1970s, his heart was set on his state flagship, the University of Massachusetts Amherst, for medical school. It offered the best deal. A rejection put him at the much pricier Boston University, where his financial aid included overseeing two undergraduate dorms filled with lively students that made it difficult for him to study. Seeking refuge, Evans took a part-time job at the famed Lahey Clinic across the street. It gave him access to the building's library, and to some of the most well-known pancreas surgeons in the world at that time. Evans arrived at the Medical College in 2009 and has helped build the institution into one of the premier places in the U.S. for the treatment of pancreatic cancer. The college's LaBahn Pancreatic Cancer Program has led the way in personalized medicine and the application of precision medicine, which is tailoring a patient's treatment based on their genetic makeup and tumor characteristics. The Seena Magowitz Pancreatic Cancer Foundation supports the college, giving more than $1.4 million to support pancreatic cancer research. Winkelman's first chemotherapy treatment made him violently sick. It was also ineffective; his cancer count continued to rise, not fall. Evans switched him to a different type of treatment, followed by radiation. Winkelman responded well. Evans was optimistic about his patient's recovery. Winkelman's tumor was localized to the pancreas. It hadn't spread to other organs, though it had encased some important blood vessels, making his tumor inoperable at most medical centers in this country. In an eight-hour surgery in 2019, Evans removed part of Winkelman's pancreas and took a vein out of his leg to reconstruct an artery the tumor had encased, a procedure developed by Medical College surgeons. Recovery was rough. Weakened, Winkelman battled a number of infections. Motorcycle rides were out of the question. He eventually sold the bike, doubting he would ever be able to handle his 800-pound motorcycle again. Winkelman sometimes struggles with survivor's guilt. So few pancreatic cancer patients reach the five-year anniversary of their diagnosis. "There is a part of me that says, 'OK, why did I get the second chance? Why did I survive?" Winkelman asked. These lingering questions fueled Winkelman's drive to do something. He wants to raise awareness about the disease, highlight the work being done at Froedtert and the Medical College and offer encouragement to cancer patients through videos he will post daily on his donation website. He knows the journey won't be easy. His longest motorcycle ride since his diagnosis was to South Dakota's Black Hills. The Alaskan journey will be about four times as long, on a much smaller bike he bought in 2024. Winkelman has worked with a trainer to build his core muscles, which he will need to fight the wind on the Alaska-Canada Highway. He expects the journey to take 18 days, or about 350 miles per day. His oldest son, Andy, is driving alongside him in an SUV that will pull a camper-trailer. "It's a crazy deal, isn't it? To think about doing this?" he said. "I know it seems insane." To his doctor, though, it's not. Evans commended Winkelman's attitude, saying he's a great example of the mind-body relationship at work. "There was never a doubt he would be here six years later, about to ride his motorcycle to some crazy place," Evans said. For more information about Winkelman's fundraising campaign, visit Kelly Meyerhofer has covered higher education in Wisconsin since 2018 but also enjoys stories off the beaten path of college campuses. She would love to hear your story, or someone's you think she should share. Contact her at kmeyerhofer@ or 414-223-5168. Follow her on X (Twitter) at @KellyMeyerhofer. This article originally appeared on Milwaukee Journal Sentinel: Cancer survivor riding to Alaska for Medical College of Wisconsin fundraiser
